Aeglea BioTherapeutics, Inc.

Q4 2024 13F Holders

Symbol
SYRE
CUSIP
00773J202
Type
Equity
Class
COM NEW
Num filings
135
Total reported value, excl. options
$1.39 B
Manager Report Date Value ($000) Shares Option Type